日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

US EUROPE AFRICA ASIA 中文
Business / Baby formula

China's mums key to Nestle baby milk deal

(Agencies) Updated: 2012-04-25 11:19

LONDON/BEIJING - The rise of the middle-class Chinese working mothers helps explain why Nestle paid nearly $12 billion for Pfizer's baby food business and could leave rivals scrambling to catch up.

Across emerging markets, nowhere more than in China, women are increasingly keeping jobs after having children -- a big driving force behind 10 percent annual growth in the $30 billion a year baby food industry.

Foreign labels such as SMA, Promil and S-26 Gold, which Nestle will get with the Pfizer deal, have a definite edge. Nestle's products include Nan, Gerber, Lactogen and Nestogen, but are less well known in China.

Baby milk was the foundation of the world's biggest food company, established in 1866 when German pharmacist Henri Nestle introduced a substitute for mothers who could not breast-feed.

Paying more for the Pfizer unit than the $10 billion that analysts had expected, Nestle trumped a bid from Danone and Mead Johnson.

The Pfizer nutrition business has 85 percent of its sales in emerging markets, and a quarter of sales in China.

Fuelled by 16 million new births a year, annual growth rates for China's baby formula market have been as high as 20 percent over the last five years. The market is forecast to double to $16 billion by 2016.

"The key strategic attraction of the deal in our view is Pfizer's No 5 position in the Chinese infant formula market where despite being global No 1 player in infant formula, Nestle has a relatively weak presence," said analyst Robert Dickinson at brokers Citi.

The Swiss giant is already market leader in milk formula in Latin America, Africa and the Middle East. This brings it the No 1 spot in Asia with its presence outside China counted too.

Globally, Nestle's baby food market share will rise to 25 percent from 19 percent - although this is likely to fall slightly after sell-offs to ensure regulatory clearance. Mead has 16 percent, Danone 14 percent and Abbott Laboratories 12 percent.

Few options for competitors

The Nestle-Pfizer business in China would only have a combined 12 percent market share behind Mead's leading 16 percent and Danone on 14 percent, but that would still be a rise from 10th place and there may be room for expansion.

Analysts looking at China expect the number of middle class households to double to 100 million by 2015.

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 日韩在线视频中文字幕 | 一级黄色网址 | 亚洲国产精品久久久久久 | 91社在线| 久久视频免费在线 | 日本不卡一区二区三区四区 | 亚洲精品中文字幕在线 | 免费av一级片 | 在线观看网站黄 | 俺也去在线视频 | 播播网色播播 | 你懂的在线免费观看 | 日本视频中文字幕 | 操操操操操操操操操操 | 免费网站在线高清观看 | 国产污| 人妖av在线 | 天天草夜夜草 | 亚洲一级理论片 | 免费在线观看a视频 | 91成人在线免费观看 | 日韩精品在线观看一区二区 | 国产一区二区三区视频在线播放 | 免费观看黄色大片 | xxx国产| 国产成人精品一区 | 九九热这里都是精品 | 香蕉色综合 | 大学生三级中国dvd 亚洲www在线观看 | 日韩在线观看不卡 | 欧美二区在线观看 | 天天操夜夜骑 | 久久亚洲影视 | 中文字幕精品视频 | 日韩欧美亚洲国产 | 香蕉视频网站在线 | 福利小视频在线 | 国产激情在线播放 | 成年人的黄色 | 成年人精品视频 | 国产自偷自拍 |